StockData
Amneal Pharmaceuticals, Inc. logo

Amneal Pharmaceuticals, Inc. (AMRX) stock

AMRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/3062% above fair value
$21.23−0.15 (-0.70%)

Close on Nov 16, 2026Market cap $6.78BP/E 43.3Yield –

Amneal Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Amneal Pharmaceuticals's price to book ratio was 215.3× on Nov 11, 2026, against 2.0× a year earlier. Over the last 5 years it ranged from 0.7× to 215.3×, with a median of 2.0×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 2026215.3×+161.4
2024Apr 30, 202453.9×+51.0
2023Dec 29, 20232.8×+1.8
2022Dec 30, 20221.0×−1.0
2021Dec 31, 20212.1×−0.2
2020Dec 31, 20202.2×−0.6
2019Dec 31, 20192.8×+1.1
2018Dec 31, 20181.7×–

More Amneal Pharmaceuticals figures

See a number that looks wrong?